Benralizumab
D3250C00034
Phase 1 mab completed
Quick answer
Benralizumab for Healthy Subjects is a Phase 1 program (mab) at AstraZeneca with 1 ClinicalTrials.gov record(s).
Program details
- Company
- AstraZeneca
- Indication
- Healthy Subjects
- Phase
- Phase 1
- Modality
- mab
- Status
- completed